TherapeuticsMD (TXMD) Depreciation & Amortization - Total (2022 - 2023)
TherapeuticsMD's (TXMD) quarterly Depreciation & Amortization - Total came in at $130000.0 in Q3 2023, down 52.38% YoY from $273000.0 in Q3 2022, and up 1.56% on a QoQ basis from $128000.0 in Q2 2023.
TherapeuticsMD (TXMD) Depreciation & Amortization - Total (2022 - 2023) Analysis & Trends
TherapeuticsMD (TXMD) has 2 years of Depreciation & Amortization - Total data on file, last reported at $130000.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Tot) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | TherapeuticsMD | 23.54 Mn | 14.35 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 130,000.00 |
| Jun 30, 2023 | 128,000.00 |
| Mar 31, 2023 | 27,000.00 |
| Sep 30, 2022 | 273,000.00 |
| Jun 30, 2022 | 282,000.00 |
| Mar 31, 2022 | 329,000.00 |